Global Hemophilia Gene Therapy Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Hemophilia Gene Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals with hemophilia experience bleeding episodes after injuries and spontaneous bleeding episodes that often lead to joint disease such as arthritis. The most frequent forms of hemophilia affect males.
Global Hemophilia Gene Therapy key players include Spark Therapeutics, Ultragenyx, Shire PLC, Sangamo Therapeutics, etc.
LPI (LP Information)' newest research report, the “Hemophilia Gene Therapy Industry Forecast” looks at past sales and reviews total world Hemophilia Gene Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Hemophilia Gene Therapy sales for 2025 through 2031. With Hemophilia Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemophilia Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Hemophilia Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hemophilia Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemophilia Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemophilia Gene Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemophilia Gene Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemophilia Gene Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Hemophilia Gene Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals with hemophilia experience bleeding episodes after injuries and spontaneous bleeding episodes that often lead to joint disease such as arthritis. The most frequent forms of hemophilia affect males.
Global Hemophilia Gene Therapy key players include Spark Therapeutics, Ultragenyx, Shire PLC, Sangamo Therapeutics, etc.
LPI (LP Information)' newest research report, the “Hemophilia Gene Therapy Industry Forecast” looks at past sales and reviews total world Hemophilia Gene Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Hemophilia Gene Therapy sales for 2025 through 2031. With Hemophilia Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemophilia Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Hemophilia Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hemophilia Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemophilia Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemophilia Gene Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemophilia Gene Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemophilia Gene Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Hemophilia A
- Hemophilia B
- Hemophilia A Gene Therapy
- Hemophilia B Gene Therapy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Spark Therapeutics
- Ultragenyx
- Shire PLC
- Sangamo Therapeutics
- Bioverativ
- BioMarin
- uniQure
- Freeline Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemophilia Gene Therapy Market Size (2020-2031)
2.1.2 Hemophilia Gene Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Hemophilia Gene Therapy by Country/Region (2020, 2024 & 2031)
2.2 Hemophilia Gene Therapy Segment by Type
2.2.1 Hemophilia A
2.2.2 Hemophilia B
2.3 Hemophilia Gene Therapy Market Size by Type
2.3.1 Hemophilia Gene Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Hemophilia Gene Therapy Market Size Market Share by Type (2020-2025)
2.4 Hemophilia Gene Therapy Segment by Application
2.4.1 Hemophilia A Gene Therapy
2.4.2 Hemophilia B Gene Therapy
2.5 Hemophilia Gene Therapy Market Size by Application
2.5.1 Hemophilia Gene Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Hemophilia Gene Therapy Market Size Market Share by Application (2020-2025)
3 HEMOPHILIA GENE THERAPY MARKET SIZE BY PLAYER
3.1 Hemophilia Gene Therapy Market Size Market Share by Player
3.1.1 Global Hemophilia Gene Therapy Revenue by Player (2020-2025)
3.1.2 Global Hemophilia Gene Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Hemophilia Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HEMOPHILIA GENE THERAPY BY REGION
4.1 Hemophilia Gene Therapy Market Size by Region (2020-2025)
4.2 Global Hemophilia Gene Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hemophilia Gene Therapy Market Size Growth (2020-2025)
4.4 APAC Hemophilia Gene Therapy Market Size Growth (2020-2025)
4.5 Europe Hemophilia Gene Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Hemophilia Gene Therapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Hemophilia Gene Therapy Market Size by Country (2020-2025)
5.2 Americas Hemophilia Gene Therapy Market Size by Type (2020-2025)
5.3 Americas Hemophilia Gene Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemophilia Gene Therapy Market Size by Region (2020-2025)
6.2 APAC Hemophilia Gene Therapy Market Size by Type (2020-2025)
6.3 APAC Hemophilia Gene Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hemophilia Gene Therapy Market Size by Country (2020-2025)
7.2 Europe Hemophilia Gene Therapy Market Size by Type (2020-2025)
7.3 Europe Hemophilia Gene Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemophilia Gene Therapy by Region (2020-2025)
8.2 Middle East & Africa Hemophilia Gene Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Hemophilia Gene Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HEMOPHILIA GENE THERAPY MARKET FORECAST
10.1 Global Hemophilia Gene Therapy Forecast by Region (2026-2031)
10.1.1 Global Hemophilia Gene Therapy Forecast by Region (2026-2031)
10.1.2 Americas Hemophilia Gene Therapy Forecast
10.1.3 APAC Hemophilia Gene Therapy Forecast
10.1.4 Europe Hemophilia Gene Therapy Forecast
10.1.5 Middle East & Africa Hemophilia Gene Therapy Forecast
10.2 Americas Hemophilia Gene Therapy Forecast by Country (2026-2031)
10.2.1 United States Market Hemophilia Gene Therapy Forecast
10.2.2 Canada Market Hemophilia Gene Therapy Forecast
10.2.3 Mexico Market Hemophilia Gene Therapy Forecast
10.2.4 Brazil Market Hemophilia Gene Therapy Forecast
10.3 APAC Hemophilia Gene Therapy Forecast by Region (2026-2031)
10.3.1 China Hemophilia Gene Therapy Market Forecast
10.3.2 Japan Market Hemophilia Gene Therapy Forecast
10.3.3 Korea Market Hemophilia Gene Therapy Forecast
10.3.4 Southeast Asia Market Hemophilia Gene Therapy Forecast
10.3.5 India Market Hemophilia Gene Therapy Forecast
10.3.6 Australia Market Hemophilia Gene Therapy Forecast
10.4 Europe Hemophilia Gene Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market Hemophilia Gene Therapy Forecast
10.4.2 France Market Hemophilia Gene Therapy Forecast
10.4.3 UK Market Hemophilia Gene Therapy Forecast
10.4.4 Italy Market Hemophilia Gene Therapy Forecast
10.4.5 Russia Market Hemophilia Gene Therapy Forecast
10.5 Middle East & Africa Hemophilia Gene Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market Hemophilia Gene Therapy Forecast
10.5.2 South Africa Market Hemophilia Gene Therapy Forecast
10.5.3 Israel Market Hemophilia Gene Therapy Forecast
10.5.4 Turkey Market Hemophilia Gene Therapy Forecast
10.6 Global Hemophilia Gene Therapy Forecast by Type (2026-2031)
10.7 Global Hemophilia Gene Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Hemophilia Gene Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Spark Therapeutics
11.1.1 Spark Therapeutics Company Information
11.1.2 Spark Therapeutics Hemophilia Gene Therapy Product Offered
11.1.3 Spark Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Spark Therapeutics Main Business Overview
11.1.5 Spark Therapeutics Latest Developments
11.2 Ultragenyx
11.2.1 Ultragenyx Company Information
11.2.2 Ultragenyx Hemophilia Gene Therapy Product Offered
11.2.3 Ultragenyx Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Ultragenyx Main Business Overview
11.2.5 Ultragenyx Latest Developments
11.3 Shire PLC
11.3.1 Shire PLC Company Information
11.3.2 Shire PLC Hemophilia Gene Therapy Product Offered
11.3.3 Shire PLC Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Shire PLC Main Business Overview
11.3.5 Shire PLC Latest Developments
11.4 Sangamo Therapeutics
11.4.1 Sangamo Therapeutics Company Information
11.4.2 Sangamo Therapeutics Hemophilia Gene Therapy Product Offered
11.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Sangamo Therapeutics Main Business Overview
11.4.5 Sangamo Therapeutics Latest Developments
11.5 Bioverativ
11.5.1 Bioverativ Company Information
11.5.2 Bioverativ Hemophilia Gene Therapy Product Offered
11.5.3 Bioverativ Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bioverativ Main Business Overview
11.5.5 Bioverativ Latest Developments
11.6 BioMarin
11.6.1 BioMarin Company Information
11.6.2 BioMarin Hemophilia Gene Therapy Product Offered
11.6.3 BioMarin Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 BioMarin Main Business Overview
11.6.5 BioMarin Latest Developments
11.7 uniQure
11.7.1 uniQure Company Information
11.7.2 uniQure Hemophilia Gene Therapy Product Offered
11.7.3 uniQure Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 uniQure Main Business Overview
11.7.5 uniQure Latest Developments
11.8 Freeline Therapeutics
11.8.1 Freeline Therapeutics Company Information
11.8.2 Freeline Therapeutics Hemophilia Gene Therapy Product Offered
11.8.3 Freeline Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Freeline Therapeutics Main Business Overview
11.8.5 Freeline Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemophilia Gene Therapy Market Size (2020-2031)
2.1.2 Hemophilia Gene Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Hemophilia Gene Therapy by Country/Region (2020, 2024 & 2031)
2.2 Hemophilia Gene Therapy Segment by Type
2.2.1 Hemophilia A
2.2.2 Hemophilia B
2.3 Hemophilia Gene Therapy Market Size by Type
2.3.1 Hemophilia Gene Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Hemophilia Gene Therapy Market Size Market Share by Type (2020-2025)
2.4 Hemophilia Gene Therapy Segment by Application
2.4.1 Hemophilia A Gene Therapy
2.4.2 Hemophilia B Gene Therapy
2.5 Hemophilia Gene Therapy Market Size by Application
2.5.1 Hemophilia Gene Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Hemophilia Gene Therapy Market Size Market Share by Application (2020-2025)
3 HEMOPHILIA GENE THERAPY MARKET SIZE BY PLAYER
3.1 Hemophilia Gene Therapy Market Size Market Share by Player
3.1.1 Global Hemophilia Gene Therapy Revenue by Player (2020-2025)
3.1.2 Global Hemophilia Gene Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Hemophilia Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HEMOPHILIA GENE THERAPY BY REGION
4.1 Hemophilia Gene Therapy Market Size by Region (2020-2025)
4.2 Global Hemophilia Gene Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hemophilia Gene Therapy Market Size Growth (2020-2025)
4.4 APAC Hemophilia Gene Therapy Market Size Growth (2020-2025)
4.5 Europe Hemophilia Gene Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Hemophilia Gene Therapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Hemophilia Gene Therapy Market Size by Country (2020-2025)
5.2 Americas Hemophilia Gene Therapy Market Size by Type (2020-2025)
5.3 Americas Hemophilia Gene Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemophilia Gene Therapy Market Size by Region (2020-2025)
6.2 APAC Hemophilia Gene Therapy Market Size by Type (2020-2025)
6.3 APAC Hemophilia Gene Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hemophilia Gene Therapy Market Size by Country (2020-2025)
7.2 Europe Hemophilia Gene Therapy Market Size by Type (2020-2025)
7.3 Europe Hemophilia Gene Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemophilia Gene Therapy by Region (2020-2025)
8.2 Middle East & Africa Hemophilia Gene Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Hemophilia Gene Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HEMOPHILIA GENE THERAPY MARKET FORECAST
10.1 Global Hemophilia Gene Therapy Forecast by Region (2026-2031)
10.1.1 Global Hemophilia Gene Therapy Forecast by Region (2026-2031)
10.1.2 Americas Hemophilia Gene Therapy Forecast
10.1.3 APAC Hemophilia Gene Therapy Forecast
10.1.4 Europe Hemophilia Gene Therapy Forecast
10.1.5 Middle East & Africa Hemophilia Gene Therapy Forecast
10.2 Americas Hemophilia Gene Therapy Forecast by Country (2026-2031)
10.2.1 United States Market Hemophilia Gene Therapy Forecast
10.2.2 Canada Market Hemophilia Gene Therapy Forecast
10.2.3 Mexico Market Hemophilia Gene Therapy Forecast
10.2.4 Brazil Market Hemophilia Gene Therapy Forecast
10.3 APAC Hemophilia Gene Therapy Forecast by Region (2026-2031)
10.3.1 China Hemophilia Gene Therapy Market Forecast
10.3.2 Japan Market Hemophilia Gene Therapy Forecast
10.3.3 Korea Market Hemophilia Gene Therapy Forecast
10.3.4 Southeast Asia Market Hemophilia Gene Therapy Forecast
10.3.5 India Market Hemophilia Gene Therapy Forecast
10.3.6 Australia Market Hemophilia Gene Therapy Forecast
10.4 Europe Hemophilia Gene Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market Hemophilia Gene Therapy Forecast
10.4.2 France Market Hemophilia Gene Therapy Forecast
10.4.3 UK Market Hemophilia Gene Therapy Forecast
10.4.4 Italy Market Hemophilia Gene Therapy Forecast
10.4.5 Russia Market Hemophilia Gene Therapy Forecast
10.5 Middle East & Africa Hemophilia Gene Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market Hemophilia Gene Therapy Forecast
10.5.2 South Africa Market Hemophilia Gene Therapy Forecast
10.5.3 Israel Market Hemophilia Gene Therapy Forecast
10.5.4 Turkey Market Hemophilia Gene Therapy Forecast
10.6 Global Hemophilia Gene Therapy Forecast by Type (2026-2031)
10.7 Global Hemophilia Gene Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Hemophilia Gene Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Spark Therapeutics
11.1.1 Spark Therapeutics Company Information
11.1.2 Spark Therapeutics Hemophilia Gene Therapy Product Offered
11.1.3 Spark Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Spark Therapeutics Main Business Overview
11.1.5 Spark Therapeutics Latest Developments
11.2 Ultragenyx
11.2.1 Ultragenyx Company Information
11.2.2 Ultragenyx Hemophilia Gene Therapy Product Offered
11.2.3 Ultragenyx Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Ultragenyx Main Business Overview
11.2.5 Ultragenyx Latest Developments
11.3 Shire PLC
11.3.1 Shire PLC Company Information
11.3.2 Shire PLC Hemophilia Gene Therapy Product Offered
11.3.3 Shire PLC Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Shire PLC Main Business Overview
11.3.5 Shire PLC Latest Developments
11.4 Sangamo Therapeutics
11.4.1 Sangamo Therapeutics Company Information
11.4.2 Sangamo Therapeutics Hemophilia Gene Therapy Product Offered
11.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Sangamo Therapeutics Main Business Overview
11.4.5 Sangamo Therapeutics Latest Developments
11.5 Bioverativ
11.5.1 Bioverativ Company Information
11.5.2 Bioverativ Hemophilia Gene Therapy Product Offered
11.5.3 Bioverativ Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bioverativ Main Business Overview
11.5.5 Bioverativ Latest Developments
11.6 BioMarin
11.6.1 BioMarin Company Information
11.6.2 BioMarin Hemophilia Gene Therapy Product Offered
11.6.3 BioMarin Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 BioMarin Main Business Overview
11.6.5 BioMarin Latest Developments
11.7 uniQure
11.7.1 uniQure Company Information
11.7.2 uniQure Hemophilia Gene Therapy Product Offered
11.7.3 uniQure Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 uniQure Main Business Overview
11.7.5 uniQure Latest Developments
11.8 Freeline Therapeutics
11.8.1 Freeline Therapeutics Company Information
11.8.2 Freeline Therapeutics Hemophilia Gene Therapy Product Offered
11.8.3 Freeline Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Freeline Therapeutics Main Business Overview
11.8.5 Freeline Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hemophilia Gene Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Hemophilia Gene Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Hemophilia A
Table 4. Major Players of Hemophilia B
Table 5. Hemophilia Gene Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Hemophilia Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Hemophilia Gene Therapy Market Size Market Share by Type (2020-2025)
Table 8. Hemophilia Gene Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Hemophilia Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Hemophilia Gene Therapy Market Size Market Share by Application (2020-2025)
Table 11. Global Hemophilia Gene Therapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Hemophilia Gene Therapy Revenue Market Share by Player (2020-2025)
Table 13. Hemophilia Gene Therapy Key Players Head office and Products Offered
Table 14. Hemophilia Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hemophilia Gene Therapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Hemophilia Gene Therapy Market Size Market Share by Region (2020-2025)
Table 19. Global Hemophilia Gene Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Hemophilia Gene Therapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Hemophilia Gene Therapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Hemophilia Gene Therapy Market Size Market Share by Country (2020-2025)
Table 23. Americas Hemophilia Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Hemophilia Gene Therapy Market Size Market Share by Type (2020-2025)
Table 25. Americas Hemophilia Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Hemophilia Gene Therapy Market Size Market Share by Application (2020-2025)
Table 27. APAC Hemophilia Gene Therapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Hemophilia Gene Therapy Market Size Market Share by Region (2020-2025)
Table 29. APAC Hemophilia Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Hemophilia Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Hemophilia Gene Therapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Hemophilia Gene Therapy Market Size Market Share by Country (2020-2025)
Table 33. Europe Hemophilia Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Hemophilia Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Hemophilia Gene Therapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Hemophilia Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Hemophilia Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Hemophilia Gene Therapy
Table 39. Key Market Challenges & Risks of Hemophilia Gene Therapy
Table 40. Key Industry Trends of Hemophilia Gene Therapy
Table 41. Global Hemophilia Gene Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Hemophilia Gene Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Hemophilia Gene Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Hemophilia Gene Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Spark Therapeutics Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 46. Spark Therapeutics Hemophilia Gene Therapy Product Offered
Table 47. Spark Therapeutics Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Spark Therapeutics Main Business
Table 49. Spark Therapeutics Latest Developments
Table 50. Ultragenyx Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 51. Ultragenyx Hemophilia Gene Therapy Product Offered
Table 52. Ultragenyx Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Ultragenyx Main Business
Table 54. Ultragenyx Latest Developments
Table 55. Shire PLC Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 56. Shire PLC Hemophilia Gene Therapy Product Offered
Table 57. Shire PLC Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Shire PLC Main Business
Table 59. Shire PLC Latest Developments
Table 60. Sangamo Therapeutics Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 61. Sangamo Therapeutics Hemophilia Gene Therapy Product Offered
Table 62. Sangamo Therapeutics Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Sangamo Therapeutics Main Business
Table 64. Sangamo Therapeutics Latest Developments
Table 65. Bioverativ Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 66. Bioverativ Hemophilia Gene Therapy Product Offered
Table 67. Bioverativ Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Bioverativ Main Business
Table 69. Bioverativ Latest Developments
Table 70. BioMarin Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 71. BioMarin Hemophilia Gene Therapy Product Offered
Table 72. BioMarin Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. BioMarin Main Business
Table 74. BioMarin Latest Developments
Table 75. uniQure Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 76. uniQure Hemophilia Gene Therapy Product Offered
Table 77. uniQure Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. uniQure Main Business
Table 79. uniQure Latest Developments
Table 80. Freeline Therapeutics Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 81. Freeline Therapeutics Hemophilia Gene Therapy Product Offered
Table 82. Freeline Therapeutics Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Freeline Therapeutics Main Business
Table 84. Freeline Therapeutics Latest Developments
Table 1. Hemophilia Gene Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Hemophilia Gene Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Hemophilia A
Table 4. Major Players of Hemophilia B
Table 5. Hemophilia Gene Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Hemophilia Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Hemophilia Gene Therapy Market Size Market Share by Type (2020-2025)
Table 8. Hemophilia Gene Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Hemophilia Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Hemophilia Gene Therapy Market Size Market Share by Application (2020-2025)
Table 11. Global Hemophilia Gene Therapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Hemophilia Gene Therapy Revenue Market Share by Player (2020-2025)
Table 13. Hemophilia Gene Therapy Key Players Head office and Products Offered
Table 14. Hemophilia Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hemophilia Gene Therapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Hemophilia Gene Therapy Market Size Market Share by Region (2020-2025)
Table 19. Global Hemophilia Gene Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Hemophilia Gene Therapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Hemophilia Gene Therapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Hemophilia Gene Therapy Market Size Market Share by Country (2020-2025)
Table 23. Americas Hemophilia Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Hemophilia Gene Therapy Market Size Market Share by Type (2020-2025)
Table 25. Americas Hemophilia Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Hemophilia Gene Therapy Market Size Market Share by Application (2020-2025)
Table 27. APAC Hemophilia Gene Therapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Hemophilia Gene Therapy Market Size Market Share by Region (2020-2025)
Table 29. APAC Hemophilia Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Hemophilia Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Hemophilia Gene Therapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Hemophilia Gene Therapy Market Size Market Share by Country (2020-2025)
Table 33. Europe Hemophilia Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Hemophilia Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Hemophilia Gene Therapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Hemophilia Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Hemophilia Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Hemophilia Gene Therapy
Table 39. Key Market Challenges & Risks of Hemophilia Gene Therapy
Table 40. Key Industry Trends of Hemophilia Gene Therapy
Table 41. Global Hemophilia Gene Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Hemophilia Gene Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Hemophilia Gene Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Hemophilia Gene Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Spark Therapeutics Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 46. Spark Therapeutics Hemophilia Gene Therapy Product Offered
Table 47. Spark Therapeutics Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Spark Therapeutics Main Business
Table 49. Spark Therapeutics Latest Developments
Table 50. Ultragenyx Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 51. Ultragenyx Hemophilia Gene Therapy Product Offered
Table 52. Ultragenyx Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Ultragenyx Main Business
Table 54. Ultragenyx Latest Developments
Table 55. Shire PLC Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 56. Shire PLC Hemophilia Gene Therapy Product Offered
Table 57. Shire PLC Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Shire PLC Main Business
Table 59. Shire PLC Latest Developments
Table 60. Sangamo Therapeutics Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 61. Sangamo Therapeutics Hemophilia Gene Therapy Product Offered
Table 62. Sangamo Therapeutics Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Sangamo Therapeutics Main Business
Table 64. Sangamo Therapeutics Latest Developments
Table 65. Bioverativ Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 66. Bioverativ Hemophilia Gene Therapy Product Offered
Table 67. Bioverativ Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Bioverativ Main Business
Table 69. Bioverativ Latest Developments
Table 70. BioMarin Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 71. BioMarin Hemophilia Gene Therapy Product Offered
Table 72. BioMarin Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. BioMarin Main Business
Table 74. BioMarin Latest Developments
Table 75. uniQure Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 76. uniQure Hemophilia Gene Therapy Product Offered
Table 77. uniQure Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. uniQure Main Business
Table 79. uniQure Latest Developments
Table 80. Freeline Therapeutics Details, Company Type, Hemophilia Gene Therapy Area Served and Its Competitors
Table 81. Freeline Therapeutics Hemophilia Gene Therapy Product Offered
Table 82. Freeline Therapeutics Hemophilia Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Freeline Therapeutics Main Business
Table 84. Freeline Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Hemophilia Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hemophilia Gene Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Hemophilia Gene Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Hemophilia Gene Therapy Sales Market Share by Country/Region (2024)
Figure 8. Hemophilia Gene Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Hemophilia Gene Therapy Market Size Market Share by Type in 2024
Figure 10. Hemophilia Gene Therapy in Hemophilia A Gene Therapy
Figure 11. Global Hemophilia Gene Therapy Market: Hemophilia A Gene Therapy (2020-2025) & ($ millions)
Figure 12. Hemophilia Gene Therapy in Hemophilia B Gene Therapy
Figure 13. Global Hemophilia Gene Therapy Market: Hemophilia B Gene Therapy (2020-2025) & ($ millions)
Figure 14. Global Hemophilia Gene Therapy Market Size Market Share by Application in 2024
Figure 15. Global Hemophilia Gene Therapy Revenue Market Share by Player in 2024
Figure 16. Global Hemophilia Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 17. Americas Hemophilia Gene Therapy Market Size 2020-2025 ($ millions)
Figure 18. APAC Hemophilia Gene Therapy Market Size 2020-2025 ($ millions)
Figure 19. Europe Hemophilia Gene Therapy Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Hemophilia Gene Therapy Market Size 2020-2025 ($ millions)
Figure 21. Americas Hemophilia Gene Therapy Value Market Share by Country in 2024
Figure 22. United States Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Hemophilia Gene Therapy Market Size Market Share by Region in 2024
Figure 27. APAC Hemophilia Gene Therapy Market Size Market Share by Type (2020-2025)
Figure 28. APAC Hemophilia Gene Therapy Market Size Market Share by Application (2020-2025)
Figure 29. China Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 33. India Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Hemophilia Gene Therapy Market Size Market Share by Country in 2024
Figure 36. Europe Hemophilia Gene Therapy Market Size Market Share by Type (2020-2025)
Figure 37. Europe Hemophilia Gene Therapy Market Size Market Share by Application (2020-2025)
Figure 38. Germany Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. France Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 52. APAC Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 53. Europe Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 55. United States Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 56. Canada Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 57. Mexico Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 58. Brazil Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 59. China Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 60. Japan Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 61. Korea Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 63. India Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 64. Australia Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 65. Germany Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 66. France Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 67. UK Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 68. Italy Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 69. Russia Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 70. Egypt Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 71. South Africa Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 72. Israel Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 73. Turkey Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 74. Global Hemophilia Gene Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Hemophilia Gene Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 1. Hemophilia Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hemophilia Gene Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Hemophilia Gene Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Hemophilia Gene Therapy Sales Market Share by Country/Region (2024)
Figure 8. Hemophilia Gene Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Hemophilia Gene Therapy Market Size Market Share by Type in 2024
Figure 10. Hemophilia Gene Therapy in Hemophilia A Gene Therapy
Figure 11. Global Hemophilia Gene Therapy Market: Hemophilia A Gene Therapy (2020-2025) & ($ millions)
Figure 12. Hemophilia Gene Therapy in Hemophilia B Gene Therapy
Figure 13. Global Hemophilia Gene Therapy Market: Hemophilia B Gene Therapy (2020-2025) & ($ millions)
Figure 14. Global Hemophilia Gene Therapy Market Size Market Share by Application in 2024
Figure 15. Global Hemophilia Gene Therapy Revenue Market Share by Player in 2024
Figure 16. Global Hemophilia Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 17. Americas Hemophilia Gene Therapy Market Size 2020-2025 ($ millions)
Figure 18. APAC Hemophilia Gene Therapy Market Size 2020-2025 ($ millions)
Figure 19. Europe Hemophilia Gene Therapy Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Hemophilia Gene Therapy Market Size 2020-2025 ($ millions)
Figure 21. Americas Hemophilia Gene Therapy Value Market Share by Country in 2024
Figure 22. United States Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Hemophilia Gene Therapy Market Size Market Share by Region in 2024
Figure 27. APAC Hemophilia Gene Therapy Market Size Market Share by Type (2020-2025)
Figure 28. APAC Hemophilia Gene Therapy Market Size Market Share by Application (2020-2025)
Figure 29. China Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 33. India Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Hemophilia Gene Therapy Market Size Market Share by Country in 2024
Figure 36. Europe Hemophilia Gene Therapy Market Size Market Share by Type (2020-2025)
Figure 37. Europe Hemophilia Gene Therapy Market Size Market Share by Application (2020-2025)
Figure 38. Germany Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. France Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Hemophilia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 52. APAC Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 53. Europe Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 55. United States Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 56. Canada Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 57. Mexico Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 58. Brazil Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 59. China Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 60. Japan Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 61. Korea Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 63. India Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 64. Australia Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 65. Germany Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 66. France Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 67. UK Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 68. Italy Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 69. Russia Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 70. Egypt Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 71. South Africa Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 72. Israel Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 73. Turkey Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 74. Global Hemophilia Gene Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Hemophilia Gene Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Hemophilia Gene Therapy Market Size 2026-2031 ($ millions)
